Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 516

1.

Essential role of stem cell factor-c-Kit signalling pathway in bleomycin-induced pulmonary fibrosis.

Ding L, Dolgachev V, Wu Z, Liu T, Nakashima T, Wu Z, Ullenbruch M, Lukacs NW, Chen Z, Phan SH.

J Pathol. 2013 Jun;230(2):205-14. doi: 10.1002/path.4177. Epub 2013 Apr 3.

2.

Characterization of lung stem cell niches in a mouse model of bleomycin-induced fibrosis.

Banerjee ER, Henderson WR Jr.

Stem Cell Res Ther. 2012 May 29;3(3):21. doi: 10.1186/scrt112.

3.

Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling.

Dolgachev VA, Ullenbruch MR, Lukacs NW, Phan SH.

Am J Pathol. 2009 Feb;174(2):390-400. doi: 10.2353/ajpath.2009.080513. Epub 2009 Jan 15.

4.

Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis.

Xu J, Mora A, Shim H, Stecenko A, Brigham KL, Rojas M.

Am J Respir Cell Mol Biol. 2007 Sep;37(3):291-9. Epub 2007 Apr 26.

5.

TGFβ signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment.

Degryse AL, Tanjore H, Xu XC, Polosukhin VV, Jones BR, Boomershine CS, Ortiz C, Sherrill TP, McMahon FB, Gleaves LA, Blackwell TS, Lawson WE.

Am J Physiol Lung Cell Mol Physiol. 2011 Jun;300(6):L887-97. doi: 10.1152/ajplung.00397.2010. Epub 2011 Mar 25.

6.
7.

Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.

Bernau K, Ngam C, Torr EE, Acton B, Kach J, Dulin NO, Sandbo N.

Respir Res. 2015 Mar 27;16:45. doi: 10.1186/s12931-015-0206-6.

8.
9.

Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.

Yasui H, Gabazza EC, Tamaki S, Kobayashi T, Hataji O, Yuda H, Shimizu S, Suzuki K, Adachi Y, Taguchi O.

Am J Respir Crit Care Med. 2001 Jun;163(7):1660-8.

PMID:
11401891
10.

The role of high mobility group box1 in pulmonary fibrosis.

Hamada N, Maeyama T, Kawaguchi T, Yoshimi M, Fukumoto J, Yamada M, Yamada S, Kuwano K, Nakanishi Y.

Am J Respir Cell Mol Biol. 2008 Oct;39(4):440-7. doi: 10.1165/rcmb.2007-0330OC. Epub 2008 Apr 25.

PMID:
18441281
11.

Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury.

Aono Y, Ledford JG, Mukherjee S, Ogawa H, Nishioka Y, Sone S, Beers MF, Noble PW, Wright JR.

Am J Respir Crit Care Med. 2012 Mar 1;185(5):525-36. doi: 10.1164/rccm.201103-0561OC. Epub 2011 Dec 28.

12.

Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.

Lan YW, Choo KB, Chen CM, Hung TH, Chen YB, Hsieh CH, Kuo HP, Chong KY.

Stem Cell Res Ther. 2015 May 20;6:97. doi: 10.1186/s13287-015-0081-6.

13.

Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: role of transmembrane SCF and the PAR-2/PKC-α/Raf-1/p44/42 signaling pathway.

Wygrecka M, Dahal BK, Kosanovic D, Petersen F, Taborski B, von Gerlach S, Didiasova M, Zakrzewicz D, Preissner KT, Schermuly RT, Markart P.

Am J Pathol. 2013 Jun;182(6):2094-108. doi: 10.1016/j.ajpath.2013.02.013. Epub 2013 Apr 4.

PMID:
23562441
14.

Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.

Ponticos M, Holmes AM, Shi-wen X, Leoni P, Khan K, Rajkumar VS, Hoyles RK, Bou-Gharios G, Black CM, Denton CP, Abraham DJ, Leask A, Lindahl GE.

Arthritis Rheum. 2009 Jul;60(7):2142-55. doi: 10.1002/art.24620.

15.

Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice.

Cai Y, Kimura S.

PLoS One. 2015 Nov 11;10(11):e0142497. doi: 10.1371/journal.pone.0142497. eCollection 2015.

16.
17.

Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.

Gou S, Zhu T, Wang W, Xiao M, Wang XC, Chen ZH.

Int Immunopharmacol. 2014 Oct;22(2):498-504. doi: 10.1016/j.intimp.2014.07.010. Epub 2014 Aug 10.

PMID:
25111852
18.

Insulin-like growth factor-I receptor blockade improves outcome in mouse model of lung injury.

Choi JE, Lee SS, Sunde DA, Huizar I, Haugk KL, Thannickal VJ, Vittal R, Plymate SR, Schnapp LM.

Am J Respir Crit Care Med. 2009 Feb 1;179(3):212-9. doi: 10.1164/rccm.200802-228OC. Epub 2008 Nov 14.

19.
20.

The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury.

Funke M, Zhao Z, Xu Y, Chun J, Tager AM.

Am J Respir Cell Mol Biol. 2012 Mar;46(3):355-64. doi: 10.1165/rcmb.2010-0155OC. Epub 2011 Oct 20.

Supplemental Content

Support Center